Nothing Special   »   [go: up one dir, main page]

SE435281B - Forfarande for framstellning av prostaglandinderivat - Google Patents

Forfarande for framstellning av prostaglandinderivat

Info

Publication number
SE435281B
SE435281B SE7701045A SE7701045A SE435281B SE 435281 B SE435281 B SE 435281B SE 7701045 A SE7701045 A SE 7701045A SE 7701045 A SE7701045 A SE 7701045A SE 435281 B SE435281 B SE 435281B
Authority
SE
Sweden
Prior art keywords
prostagland
ingredients
procedure
preparation
prostagland ingredients
Prior art date
Application number
SE7701045A
Other languages
English (en)
Other versions
SE7701045L (sv
Inventor
U F Axen
F H Lincoln
R A Johnson
R C Kelly
J E Pike
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of SE7701045L publication Critical patent/SE7701045L/sv
Publication of SE435281B publication Critical patent/SE435281B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C07D307/937Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D313/00Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
SE7701045A 1976-02-04 1977-02-01 Forfarande for framstellning av prostaglandinderivat SE435281B (sv)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US65511076A 1976-02-04 1976-02-04
US71677176A 1976-08-23 1976-08-23
US71677076A 1976-08-23 1976-08-23
US71696076A 1976-08-23 1976-08-23
US71696976A 1976-08-23 1976-08-23
US71697276A 1976-08-23 1976-08-23
US72554876A 1976-09-22 1976-09-22

Publications (2)

Publication Number Publication Date
SE7701045L SE7701045L (sv) 1977-08-05
SE435281B true SE435281B (sv) 1984-09-17

Family

ID=27569874

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7701045A SE435281B (sv) 1976-02-04 1977-02-01 Forfarande for framstellning av prostaglandinderivat

Country Status (13)

Country Link
JP (1) JPS5936911B2 (sv)
BE (1) BE851122A (sv)
CA (3) CA1160627A (sv)
CH (2) CH632245A5 (sv)
DE (1) DE2702553C2 (sv)
FR (3) FR2359125B1 (sv)
GB (1) GB1554044A (sv)
HK (1) HK9385A (sv)
IL (1) IL51189A (sv)
MX (1) MX4811E (sv)
NL (2) NL185515C (sv)
NZ (1) NZ183050A (sv)
SE (1) SE435281B (sv)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH629493A5 (en) * 1976-05-11 1982-04-30 Wellcome Found Processes for preparing novel prostaglandin derivatives
GB1583961A (en) * 1976-05-11 1981-02-04 Wellcome Found Prostacyclin and derivatives thereof
GB1595056A (en) * 1976-10-12 1981-08-05 Wellcome Found Pharmaceutical combination
AU511711B2 (en) * 1976-12-30 1980-09-04 Upjohn Company, The 6-Oxo and 5, 6-Dihalo prostaglandin analogues
FI71138C (fi) * 1976-12-31 1986-11-24 Erba Farmitalia Foerfarande foer framstaellning av terapeutiskt aktiva bisykliska prostaglandiner
AU524786B2 (en) * 1977-03-07 1982-10-07 The Upjohn Company Prostacyclins
JPS53136513A (en) * 1977-05-06 1978-11-29 Ono Pharmaceut Co Ltd Stabilization of prostaglandin-x-related compounds
JPS6022710B2 (ja) * 1977-09-16 1985-06-03 小野薬品工業株式会社 プロスタグランジン類似化合物
DE2743283A1 (de) * 1977-09-27 1979-04-05 Hoechst Ag Neue prostacyclin-analoga
IT1088036B (it) 1977-11-25 1985-06-04 Erba Carlo Spa 15-epi-prostaciclina e prostaciclina analoghi
US4705806A (en) * 1978-02-13 1987-11-10 Morton Jr Douglas R Prostacyclin analogs
DE2811950A1 (de) * 1978-03-18 1979-12-13 Hoechst Ag Neue analoga von prostacyclin
IT1099575B (it) * 1978-07-20 1985-09-18 Erba Carlo Spa 20-metil-13,14-deidro-pgi2' suoi sali e suoi 16s- e 16r-metil derivati
DE2834248A1 (de) * 1978-08-04 1980-02-28 Hoechst Ag Neue prostaglandinderivate in der delta 2-pgf tief 2 und delta 2-pge tief 2 -reihe
US4180657A (en) * 1978-08-14 1979-12-25 The Upjohn Company Acyl-substituted phenyl esters of prostacyclin-type compounds
JPS56122372A (en) * 1980-03-03 1981-09-25 Toray Ind Inc Prostaglandin i2 derivative
DE3029984C2 (de) * 1980-08-08 1983-12-15 Grünenthal GmbH, 5190 Stolberg 2-Oxabicyclo [3.3.0] octanderivate und diese enthaltende Arzneimittel
CH648556A5 (de) * 1981-03-11 1985-03-29 Hoffmann La Roche Fluorprostacycline.
JPS595155A (ja) * 1982-06-30 1984-01-12 Ono Pharmaceut Co Ltd プロスタグランジンd類似化合物
US5591887A (en) * 1987-04-30 1997-01-07 R-Tech Ueno, Ltd. Prostaglandins of the F series
US5221763A (en) * 1987-04-30 1993-06-22 R-Tech Ueno, Ltd. Prostaglandins of the F series
CA1324129C (en) * 1987-04-30 1993-11-09 Ryuzo Ueno Prostaglandins of the f series
US5185374A (en) * 1988-05-11 1993-02-09 K.K. Ueno Seiyaku Oyo Kenkyujo Use of 15-ketoprostaglandin E or F compounds for uterine contraction
AU619543B2 (en) * 1988-05-11 1992-01-30 Sucampo Ag Use of 15-ketoprostaglandin e or f compounds for uterine contraction
WO2011013651A1 (ja) 2009-07-28 2011-02-03 小野薬品工業株式会社 二環式化合物およびその医薬用途
EP2669279B1 (en) 2011-01-27 2017-01-11 ONO Pharmaceutical Co., Ltd. Bicyclic compound and use thereof for medical purposes
CN116143742B (zh) * 2023-02-27 2024-10-18 广州楷石生物科技有限公司 依前列醇一氧化氮供体药物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2351112A1 (fr) * 1975-10-21 1977-12-09 Wellcome Found Derive de prostaglandine et medicament contenant ce derive
CH629493A5 (en) * 1976-05-11 1982-04-30 Wellcome Found Processes for preparing novel prostaglandin derivatives
MX4813E (es) * 1976-06-01 1982-10-19 Upjohn Co Procedimiento para preparar analogos de prostaglandinas
AU511711B2 (en) * 1976-12-30 1980-09-04 Upjohn Company, The 6-Oxo and 5, 6-Dihalo prostaglandin analogues

Also Published As

Publication number Publication date
CH632245A5 (en) 1982-09-30
FR2362834A1 (fr) 1978-03-24
CA1160628A (en) 1984-01-17
NL7700896A (nl) 1977-08-08
IL51189A0 (en) 1977-02-28
FR2362834B1 (sv) 1980-08-08
CA1160627A (en) 1984-01-17
FR2362833A1 (fr) 1978-03-24
CH637949A5 (en) 1983-08-31
NL185515C (nl) 1990-05-01
NL8300921A (nl) 1983-07-01
FR2359125B1 (fr) 1985-11-15
GB1554044A (en) 1979-10-17
NL185515B (nl) 1989-12-01
JPS5295644A (en) 1977-08-11
NZ183050A (en) 1979-06-08
FR2359125A1 (fr) 1978-02-17
JPS5936911B2 (ja) 1984-09-06
MX4811E (es) 1982-10-19
HK9385A (en) 1985-02-08
CA1179335A (en) 1984-12-11
SE7701045L (sv) 1977-08-05
DE2702553C2 (de) 1986-02-20
FR2362833B1 (sv) 1980-08-08
BE851122A (fr) 1977-08-04
IL51189A (en) 1985-08-30
DE2702553A1 (de) 1977-08-18

Similar Documents

Publication Publication Date Title
SE435281B (sv) Forfarande for framstellning av prostaglandinderivat
SE441827B (sv) Forfarande for framstellning av fenoxiaminopropanoler
SE7700032L (sv) Framstellning av n-fosfonometylglysin
NO774404L (no) Fremgangsmaate for fremstilling av dimetyleter
SE441354B (sv) Forfarande for framstellning av meta-fenoxibensaldehyd
SE435387B (sv) Forfarande for framstellning av antracyklinglykosider
NO143992C (no) Fremgangsmaate for fremstilling av heksanitrostilben
SE437833B (sv) Forfarande for framstellning av 7-beta-oxiiminoacylcefalosporiner
NO834236L (no) Fremgangsmaate for fremstilling av 4-halogen-dihydropyran-derivater
SE436647B (sv) Forfarande for framstellning av prostaglandinderivat (prostacyclin)
SE431207B (sv) Forfarande for framstellning av tiazolidinderivat
SE435510B (sv) Analogiforfarande for framstellning av 3-fluor-6-piperazinylmorfantridiner
SE7707621L (sv) Forfarande for framstellning av xyloslosning
SE7707407L (sv) Forfarande for framstellning av cefamderivat
SE7707471L (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
NO774067L (no) Fremgangsmaate for fremstilling av cellulosemasse
NO139555C (no) Fremgangsmaate for fremstilling av fosgen
SE7712218L (sv) Forfarande for framstellning av 4a-aryloktahydro-1h-2-pyrindiner
SE431450B (sv) Mellanprodukt till anvendning for framstellning av prostaglandinderivat
SE7706262L (sv) Forfarande for framstellning av kvadratsyra
RO77308A (ro) Procedeu pentru prepararea derivatiilor aminochinazolinei substituite
SE7702071L (sv) Forfarande for framstellning av sulfoacetaler
SE7709142L (sv) Forfarande for framstellning av 1-aryloxi-3-amino-propan-2-oler
SE428016B (sv) Forfarande for framstellning av 6a,10a-cis - hexahydrodibensopyranonderivat
SE427109B (sv) Forfarande for framstellning av 16-fluorsubstituerade prostaglandinderivat

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7701045-2

Effective date: 19880125

Format of ref document f/p: F